Spedra
Spedra is a prescription medication containing the active ingredient avanafil, which belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors. It works by helping to relax the blood vessels in the penis, enabling an increased flow of blood into the penis during sexual stimulation. It is notable for its rapid onset of action, often working within 15 to 30 minutes.
Dosage by Body Weight
The recommended starting dose is 100 mg, taken orally as needed approximately 15 to 30 minutes before sexual activity. Based on individual efficacy and tolerability, the dose may be increased to a maximum of 200 mg or decreased to 50 mg. The maximum recommended dosing frequency is once per day. It is only effective in the presence of sexual stimulation. Not indicated for use in individuals under 18 years of age.
- Body Weight
- Below 5 kg
- Dose
- Contraindicated
- Frequency
- Do not use
- Tracking Notes
- Spedra is not indicated for pediatric patients. Safe use in children has not been established.
- Body Weight
- 5-7 kg
- Dose
- Contraindicated
- Frequency
- Do not use
- Tracking Notes
- Spedra is not indicated for pediatric patients. Safe use in children has not been established.
- Body Weight
- 8-10 kg
- Dose
- Contraindicated
- Frequency
- Do not use
- Tracking Notes
- Spedra is not indicated for pediatric patients. Safe use in children has not been established.
- Body Weight
- 11-15 kg
- Dose
- Contraindicated
- Frequency
- Do not use
- Tracking Notes
- Spedra is not indicated for pediatric patients. Safe use in children has not been established.
- Body Weight
- 16-20 kg
- Dose
- Contraindicated
- Frequency
- Do not use
- Tracking Notes
- Spedra is not indicated for pediatric patients. Safe use in children has not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Contraindicated | Do not use | Spedra is not indicated for pediatric patients. Safe use in children has not been established. |
| 5-7 kg | Contraindicated | Do not use | Spedra is not indicated for pediatric patients. Safe use in children has not been established. |
| 8-10 kg | Contraindicated | Do not use | Spedra is not indicated for pediatric patients. Safe use in children has not been established. |
| 11-15 kg | Contraindicated | Do not use | Spedra is not indicated for pediatric patients. Safe use in children has not been established. |
| 16-20 kg | Contraindicated | Do not use | Spedra is not indicated for pediatric patients. Safe use in children has not been established. |